In Reply We appreciate the Letters about our Clinical Guidelines Synopsis for the management of NAFLD, now more commonly referred to as metabolic dysfunction–associated steatotic liver disease (MASLD). Dr Spacek questions the clinical impact of early detection and treatment of MASLD on all-cause mortality. Dr Braillon focuses on the consequences of including alcohol use in the diagnosis of MASLD.
Search Results for: Linee guida tedesche sulla steatosi epatica non alcolica (NAFLD)
Here's what we've found for you
Prime linee guida per Long Covid, riguardano il 6% dei pazienti
Progetto Pascnet contro la nuova emergenza di sanità pubblica
Exploration of Latina/Hispanic womens experiences living with non-alcoholic fatty liver disease: a qualitative study with patients in Houston
Objectives
A deeper understanding of the lived experiences of Hispanic patients with non-alcoholic fatty liver disease (NAFLD) can help guide the development of behavioural programmes that facilitate NAFLD management. This paper explores Hispanic women’s experiences living with NAFLD.
Design, setting, participants
We collected brief sociodemographic questionnaires and conducted in-depth interviews with 12 low-income (all had household income ≤USD$55 000 per year) Hispanic women with NAFLD from the Houston area. Transcripts were audio-recorded and transcribed. We developed a coding scheme and used thematic analysis to identify emergent themes, supported by Atlas.ti.
Results
Participants identified physicians as their main information source on NAFLD but also consulted the internet, family, friends and peers. Many were still left wanting more information. Participants identified family history, sedentary lifestyles, poor diet and comorbid conditions as causes for their NAFLD. Participants also reported emotional distress after diagnosis. Participants experienced both successes and challenges in making lifestyle changes in nutrition and physical activity. Some participants received desired social support in managing NAFLD, although there were conflicting feelings about spousal support.
Conclusion
Multifaceted programming that improves patient–provider communication, conveys accurate information and enhances social support is needed to support Hispanic women in managing NAFLD.
Linee guida sulla valutazione e gestione della malattia renale cronica
Le linee guida per la pratica clinica KDIGO 2024 per […]
Linee guida sulla diagnosi e gestione del cancro al polmone
Questa linea guida pubblicata da NICE in aggiornamento, copre la […]
Trattamento dell’insufficienza cardiaca con frazione di eiezione ridotta
Sono state aggiornate a cura dell’American College of Cardiology le linee […]
Linea guida sulla gestione della pancreatite acuta
L’American College of Gastroenterology ha pubblicato sulla rivista “American Journal […]
Carenza di vitamina B12: diagnosi e gestione
Questa linea guida pubblicata da NICE, riguarda il riconoscimento, la diagnosi […]
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic liver disease globally and is currently estimated to affect up to 38% of the global adult population. NAFLD is a multisystem disease where systemic insulin resistance and related metabolic dysfunction play a pathogenic role in the development of NAFLD and its most relevant liver-related morbidities (cirrhosis, liver failure and hepatocellular carcinoma) and extrahepatic complications, such as cardiovascular disease (CVD), type 2 diabetes mellitus, chronic kidney disease, and certain types of extrahepatic cancers. In 2023, three large multinational liver associations proposed that metabolic dysfunction-associated steatotic liver disease (MASLD) should replace the term NAFLD; the name chosen to replace non-alcoholic steatohepatitis was metabolic dysfunction-associated steatohepatitis (MASH). Emerging epidemiological evidence suggests an excellent concordance rate between NAFLD and MASLD definitions—that is, ~99% of individuals with NAFLD meet MASLD criteria. In this narrative review, we provide an overview of the literature on (a) the recent epidemiological data on MASLD and the risk of developing CVD and malignant complications, (b) the underlying mechanisms by which MASLD (and factors strongly linked with MASLD) may increase the risk of these extrahepatic complications and (c) the diagnosis and assessment of CVD risk and potential treatments to reduce CVD risk in people with MASLD or MASH.
L'aorta diventa 'organo', nuove linee guida internazionali
Coinvolto cardiochirurgo del Sant’Orsola, ‘sfida è prevenzione’
Diagnosi e gestione iniziale dell’ipertensione
Riferimenti: Practice Guidelines – 2024 European Society of Hypertension clinical […]
The Interplay Between Diabetes, Nonalcoholic Fatty Liver Disease, and Cardiovascular Disease
NAFLD was associated with excess cardiovascular risk regardless of diabetes status.
Su Odg.it guida per comunicazione rispettosa della disabilità
Curata da Arrigoni, Malafarina e Sani e promossa dalla Cpo
Self-management behaviours in adults with non-alcoholic fatty liver disease: a cross-sectional survey from China
Objectives
The prevalence of non-alcoholic fatty liver disease (NAFLD) in China has significantly increased due to changing lifestyles and rising obesity rates. Effective self-management behaviours are crucial for reversing NAFLD. This study aimed to assess the current self-management status and the influencing factors among the Chinese NAFLD population.
Design
A cross-sectional study.
Setting
This was a study conducted between 30 May 2022 and 30 May 2023 at a tertiary care hospital.
Participants
A total of 380 patients diagnosed with NAFLD were included in this study. NAFLD patients included in this study were diagnosed by FibroScan and had a controlled attenuation parameter ≥248 dB/m.
Primary outcomes and measures
The primary outcomes were self-management, demographic characteristics and clinical features of patients with NAFLD. Self-management-related domains were assessed using the self-management questionnaire of NAFLD.
Results
The study included 380 patients with an average age of 42.79±13.77 years, with 62.89% being male. The mean score on the self-management scale was 80.92±18.31, indicating a low level of self-management behaviours. Among the five dimensions of the self-management scale, lifestyle management received the highest score (10.68±2.53), while disease knowledge management received the lowest score (9.29±2.51). Furthermore, gender (β=0.118, p=0.009), education level (β=0.118, p=0.010), body mass index (BMI) (β=–0.141, p=0.002) and sleep quality (β=0.387, p
Linee guida sulla sindrome dell’occhio secco.
L’American Academy of Ophthalmology ha pubblicato una linea guida sulla […]
Linee guida cliniche sulla gestione dell’obesità
La Società Italiana d’Igiene, Medicina Preventiva e Sanità Pubblica (SItI) […]